Genetic Determinants of Warfarin Dosing in the Han-Chinese Population
- 3 December 2009
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 10 (12) , 1905-1913
Abstract
Warfarin, a widely prescribed oral anticoagulant, is used for the prevention of thromboembolism. Polymorphisms in CYP2C9 and VKORC1 have been shown to be associated with warfarin dose requirements. However, it is likely that other genes could also affect warfarin dose. Aims: In this study, we aimed to identify additional genes influencing warfarin dosing in the Han-Chinese population. Materials & methods: In this study, we screened for SNPs in 13 genes (VKORC1, CYP2C9, CYP2C18, PROC, APOE, EPHX1, CALU, GGCX, ORM1, ORM2, factor II, factor VII and CYP4F2) and tested their associations with warfarin dosing with univariate and multiple regression analysis. Results: Polymorphisms in the VKORC1 gene have the strongest effects on warfarin dose, followed by CYP2C9*3. In addition, our results showed that CYP2C18, PROC and EPHX1 have small but significant associations with warfarin dose. In multiple regression analysis, PROC and EPHX1 explained 3% of the dose variation. The incorporation of these two genes into war...Keywords
Funding Information
- National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC97–3112-B-001–014)
- National Genotyping Center (NSC97–3112-B -001–015)
This publication has 48 references indexed in Scilit:
- Anticoagulant-induced intracerebral bleeding in brain ischemiaActa Neurologica Scandinavica, 2009
- Novel genetic variants in Asian subjects and their influence on maintenance warfarin doseClinical Pharmacology & Therapeutics, 2004
- Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patientsClinical Pharmacology & Therapeutics, 2003
- Interindividual variability in sensitivity to warfarin-Nature or nurture?Clinical Pharmacology & Therapeutics, 2001
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998
- Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart ValvesChest, 1995
- Antithrombotic Therapy in Atrial FibrillationChest, 1995
- Bleeding complications to long-term oral anticoagulant therapyJournal of Thrombosis and Thrombolysis, 1994
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993
- Antithrombotic therapy in deep vein thrombosis and pulmonary embolismAmerican Heart Journal, 1992